Search for: "Christine Lay" Results 101 - 120 of 141
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Apr 2021, 1:05 am by Kluwer Patent blogger
The greatest challenge for IP in the area of artificial intelligence (AI) will be to achieve some level of harmonisation worldwide. [read post]
4 Dec 2022, 4:00 am by SOQUIJ
PRESCRIPTION EXTINCTIVE — délai — action collective — recours en dommages-intérêts — connaissance de la cause d’action — faute continue — dommages continus — point de départ du calcul du délai. [read post]
27 Apr 2023, 5:50 am by Kevin Klyman
Consequently, China’s top three semiconductor firms have had to delay production at new factories, leading firms like memory chip giant YMTC to lay off 10 percent of its staff. [read post]
24 Apr 2023, 6:16 pm
Robin Hui Huang and Christine Menglu Wang analyse the cases of the FinVolution Group and Ant Group to find answers and point out loopholes in current regulation.The questions raised are central to the debates both about the character of Social credit as law, norm, or method, and the interlinking between traditional modalities of law (grounded in administrative discretion and centered on officials, and the more integrative modalities of a social credit system that affects social relations… [read post]
3 Mar 2021, 8:05 am by Bill Priestap, Holden Triplett
This capability suggested that Russia may also have been looking to lay the groundwork for a future disruption. [read post]
4 May 2021, 9:46 am by INFORRM
Laying the Foundations of the Post-Nolan Era Ever since the Tories came to power in 2010, the role of the Commissioner has gradually been reduced and political patronage in the making of public appointments has once again increased. [read post]
22 Jun 2018, 7:46 am by Jim Sedor
Christine Porath, a Georgetown University professor and author of “Mastering Civility,” said the current harsh climate was affecting people beyond politics, injecting itself into everyday life at home and work. [read post]
8 May 2011, 12:52 pm by AdamSmith1776
It maintains a balanced tone; neither lays blame nor obfuscates; nods respectfully toward counterarguments. [read post]
15 Apr 2011, 10:34 am by Josh Wright
   A fuller development of the case for skepticism about behavioral law and economics can wait for the article; it suffices for now to lay out a few of the most incredible aspects of Korobkin’s claims. [read post]
12 Mar 2023, 4:00 am by SOQUIJ
Le délai entre le dernier événement et les rencontres respectives que les policiers ont tenues avec les plaignantes et avec l’appelant était le même. [read post]
3 Sep 2009, 10:07 am by Christine Kirchberger
Within the field of legal informatics, discussions often focus on the technical and methodological questions of access to legal information. [read post]
10 Jun 2022, 4:22 am by Philip Mousavizadeh
Anushka Patil reports for the New York Times The European Central Bank (ECB) will raise interest rates for the first time in 11 years, President Christine Lagarde said yesterday. [read post]
15 Feb 2011, 2:56 pm by Nick Holmes
Responsibility for the SLD then lay with the Statutory Publications Office (SPO), part of the Ministry of Justice. [read post]
23 Oct 2022, 7:03 pm by Guest Author
Beyond these very practical questions, the case also could lay the groundwork for a full-scale review of Humphrey’s Executor. [read post]
7 Jan 2021, 8:30 pm by Jim Sedor
National/Federal Aides Weigh Resignations, Removal Options as Trump Rages Against Perceived Betrayals MSN – Philip Rucker, Josh Dawsey, Shane Harris, and Ashley Parker (Washington Post) | Published: 1/7/2021 President Trump was ensconced in the White House residence, raging about perceived betrayals, as an array of top aides weighed resigning and some senior administration officials began conversations about invoking the 25th Amendment – an extraordinary measure that would remove… [read post]
9 Mar 2020, 1:21 pm by Unknown
Biosimilar Markets   [I entered in media res]· Eva Temkin, Acting Director for Policy, Office of Therapeutic Biologics and Biosimilars,  CDER, FDA  · Christine Simmon, Executive Director, Biosimilars Council, AAM: barriers to entry for biosimilars: exclusionary contracts, rebates, stakeholder misinformation. misinformation can include explicit and implicit, including policies such as naming conventions and the very existence of the interchangeable category,… [read post]